PR NEWSWIRE

Previous Stories

The University of Technology Sydney (UTS) launches international campaign inspiring learners to seize the opportunities of Industry 5.0

Jan 10 2023 - PR NewsWire

UTS’s latest campaign is inspiring lifelong learners to create a more human-centric, sustainable and resilient world as they enter the…


DroneShield Announces A Second $11 million Sale, Strong Momentum into 2023

Jan 10 2023 - PR NewsWire

SYDNEY, Jan. 10, 2023 /PRNewswire/ — DroneShield Ltd (ASX:DRO) (DroneShield or the Company) is pleased to advise a second record…


Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy

Jan 10 2023 - PR NewsWire

U.S. now open for enrollment of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Jan. 9, 2023 /PRNewswire/ – Alterity…


Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update

Jan 09 2023 - PR NewsWire

MELBOURNE, Australia, Jan. 9, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at…


Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)

Jan 06 2023 - PR NewsWire

MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2023 /PRNewswire/ — Alterity Therapeutics Limited ("Alterity" or the "Company") (ASX:ATH, NASDAQ:ATHE), a…


Nintex Appoints Jen Bailin As Its New Chief Commercial Officer

Jan 06 2023 - PR NewsWire

Company appoints industry exec to lead Sales and Marketing for the Nintex Process Platform MELBOURNE, Australia, Jan. 6, 2023 /PRNewswire/…


Web3 sports tech startup Play Today launches with $1.2m investment from Clive Mayhew

Jan 05 2023 - PR NewsWire

SYDNEY, Jan. 5, 2023 /PRNewswire/ — Tech entrepreneur, investor, and chair of Fishburners Clive Mayhew has invested $1.2 million to…


Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum

Jan 04 2023 - PR NewsWire

MELBOURNE, Australia and SAN FRANCISCO, Jan. 3, 2023 /PRNewswire/ — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology…


Analog Devices and Seeing Machines Work Together to Accelerate Safer Driving Through Sophisticated Advanced Driver Assistance Systems

Jan 04 2023 - PR NewsWire

WILMINGTON, Mass. and CANBERRA, Australia, Jan. 3, 2023 /PRNewswire/ – Analog Devices, Inc. (Nasdaq: ADI), a global semiconductor leader, and Seeing…


Seeing Machines’ world-leading interior sensing technology on show in suite and in car, at CES 2023

Jan 03 2023 - PR NewsWire

CANBERRA, Australia, Jan. 2, 2023 /PRNewswire/ – Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered…


Analyse The Market From A Different Angle